causal
Regulatory Validation Locks In Instrument And Consumables
Because quality control processes are often written into FDA drug approvals with exact instruments and consumables named, customers find it expensive and risky to switch, which produces recurring revenue from consumables and service.
causalpending
Speaker
MarcEvidence Quote
“Once that happens and it's approved, it's expensive for the customer to move to a different instrument. And also there's some risks attached with that.”
Created: 11/12/2026, 11:55:35 AM
Your notes
Loading notes...